CL

China Life Healthcare Fund

Asia, Beijing, China, Beijing

Description

China Life Healthcare Fund is an investment Firm.

Investor Profile

China Life Healthcare Fund has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Series C rounds (top funding stages).
  • Majority of deals are located in China, United States.
  • Strong thematic focus on Biotechnology, Health Care, Artificial Intelligence (AI).

Stage Focus

  • Series Unknown (50%)
  • Series C (50%)

Country Focus

  • China (50%)
  • United States (50%)

Industry Focus

  • Biotechnology
  • Health Care
  • Artificial Intelligence (Ai)
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does China Life Healthcare Fund frequently co-invest with?

CICC
Asia, Beijing, China, Beijing
Co-Investments: 1
GL Ventures LLC
Asia, Beijing, China, Beijing
Co-Investments: 1
China Asset Management
Asia, Beijing, China, Beijing
Co-Investments: 1
CA
North America, Massachusetts, United States, Boston
Co-Investments: 1
PICC Capital Investment Management
Asia, Shanghai, China, Shanghai
Co-Investments: 2
Forebright Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
FutureX Capital
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
CD Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
GP Healthcare Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
ABC International
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1

What are some of recent deals done by China Life Healthcare Fund?

Jenscare Biotech

Ningbo, Zhejiang, China

Ningbo Jenscare Scientific is a medical device company.

BiotechnologyHealth Care
Series UnknownMay 28, 2021
XtalPi

Cambridge, Massachusetts, United States

XtalPi is a pharmaceutical technology company that is reinventing drug discovery by enabling dry lab predictions with wet lab validation.

Artificial Intelligence (AI)BiotechnologyPharmaceutical
Series CSep 28, 2020
Amount Raised: $318,800,000

Find More Investors Like China Life Healthcare Fund

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

China Life Healthcare Fund | Pipeseed